{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:43:23Z","timestamp":1769705003288,"version":"3.49.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cutaneous melanoma (CM) is among the most aggressive human malignancies characterised by its strong propensity for metastasis. Recent advances in melanoma research have reframed the disease as a systemic condition driven by dynamic interactions between tumour cells, the tumour microenvironment and the immune system. Increasing evidence indicates that these interactions are largely mediated by extracellular vesicles (EVs), small lipid-bilayer-enclosed particles that facilitate intercellular communication. EVs can be isolated from all biofluids, making them attractive minimally invasive biomarkers for diagnosis, staging, monitoring response to treatment and predicting relapse. Despite growing interest, a comprehensive overview of global research trends in this area is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a bibliometric systematic review of EVs-related CM research from 2005 to 2025 using Web of Science, Scopus, and EMBASE. Eligible studies focused on EVs characterisation, biomarker development, and functional roles in melanoma. Data were analysed using the\n                      <jats:italic>Bibliometrix<\/jats:italic>\n                      R-package to assess publication trends, citation metrics, author networks, institutional output and thematic evolution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      An analysis of the 288 included studies revealed that publication activity peaked in 2020, representing a 4000% increase in annual output compared to 2005. Additionally, a marked surge in citation frequency was observed beginning in 2018. The United States and China led in output, although international collaboration was limited. Chongqing Medical University and the University of Pittsburgh were among the most productive institutions. The\n                      <jats:italic>Journal of Extracellular Vesicles<\/jats:italic>\n                      published the highest number of articles in this field. Keyword and co-citation analysis identified major research themes, including immune evasion, biomarker discovery, and therapy resistance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This first bibliometric analysis of EV research in CM reveals a rapidly expanding field with evolving research priorities. These findings offer a data-driven framework to guide future studies, promote collaboration, and inform strategic investment in EVs-based melanoma research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1731250","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:22:33Z","timestamp":1769664153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A bibliometric systematic review of extracellular vesicles in cutaneous malignant melanoma from 2005 to 2025"],"prefix":"10.3389","volume":"16","author":[{"given":"Natasha","family":"Christodoulides","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, St James\u2019 Hospital","place":["Dublin, Ireland"]},{"name":"School of Pharmacy and Pharmaceutical Sciences, Trinity College","place":["Dublin, Ireland"]},{"name":"Trinity Biomedical Sciences Institute, Trinity College","place":["Dublin, Ireland"]},{"name":"Trinity St. James's Cancer Institute, Department of Pharmacy and Pharmaceutical Sciences","place":["Dublin, Ireland"]},{"name":"Royal College of Surgeons in Ireland","place":["Dublin, Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Bollard","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, St James\u2019 Hospital","place":["Dublin, Ireland"]},{"name":"Royal College of Surgeons in Ireland","place":["Dublin, Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashna","family":"Chabria","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Trinity College","place":["Dublin, Ireland"]},{"name":"Trinity Biomedical Sciences Institute, Trinity College","place":["Dublin, Ireland"]},{"name":"Trinity St. James's Cancer Institute, Department of Pharmacy and Pharmaceutical Sciences","place":["Dublin, Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"O\u2019Driscoll","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Trinity College","place":["Dublin, Ireland"]},{"name":"Trinity Biomedical Sciences Institute, Trinity College","place":["Dublin, Ireland"]},{"name":"Trinity St. James's Cancer Institute, Department of Pharmacy and Pharmaceutical Sciences","place":["Dublin, Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Potter","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, St James\u2019 Hospital","place":["Dublin, Ireland"]},{"name":"Trinity St. James's Cancer Institute, Department of Pharmacy and Pharmaceutical Sciences","place":["Dublin, Ireland"]},{"name":"Royal College of Surgeons in Ireland","place":["Dublin, Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"B1","unstructured":"What is melanoma skin cancer\n          \n          \n          \n          2025"},{"key":"B2","unstructured":"About Melanoma Skin Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-008-0067-y","article-title":"Melanoma and the tumor microenvironment","volume":"10","author":"Villanueva","year":"2008","journal-title":"Curr Oncol Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22190","article-title":"Immune system and melanoma biology: a balance between immunosurveillance and immune escape","volume":"8","author":"Passarelli","year":"2017","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.07.002","article-title":"Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis","volume":"44","author":"Suman","year":"2023","journal-title":"Trends Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102740","article-title":"The roles of extracellular vesicles in Malignant melanoma","volume":"10","author":"Cheng","year":"2021","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracellular Vesicles"},{"key":"B8","volume-title":"Extracellular vesicles and melanoma: New perspectives on tumour microenvironment and metastasis","author":"Benito-Martin","year":"2023"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumour immunity and memory","volume":"144","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15033","article-title":"PDL1-positive exosomes suppress antitumor immunity by inducing tumor-specific CD8+ T cell exhaustion during metastasis","volume":"112","author":"Chen","year":"2021","journal-title":"Cancer Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181522","article-title":"Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation","volume":"216","author":"Garc\u00eda-Silva","year":"2019","journal-title":"J Of Exp Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705206114","article-title":"BRAF V600 inhibition alters the microRNA cargo in the vesicular secretome of Malignant melanoma cells","author":"Lunavat","year":"2017","journal-title":"PNAS"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbusres.2021.04.070","article-title":"How to conduct a bibliometric analysis: An overview and guidelines","volume":"133","author":"Donthu","year":"2021","journal-title":"J Business Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.joi.2017.08.007","article-title":"bibliometrix: An R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetrics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan: a web and mobile app for systematic reviews","author":"Ouzzani","year":"2016","journal-title":"Systematic Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5530\/jscires.8.3.32","article-title":"Bibliometric analysis using bibliometrix an R package","volume":"8","author":"Dervi\u015f","year":"2020","journal-title":"J Scientometric Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1108\/LHT-09-2020-0218","article-title":"Bibliometric analysis of ecopreneurship using VOSviewer and RStudio Bibliometrix, 1989-2019","volume":"39","author":"Guleria","year":"2021","journal-title":"Library Hi Tecj"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1045763","article-title":"Bibliometric analysis of publication trends and research hotspots in vagus nerve stimulation: A 20-year panorama","volume":"13","author":"Li","year":"2022","journal-title":"Front Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijsu.2020.12.008","article-title":"Impact of the coronavirus (COVID-19) pandemic on scientific research and implications for clinical academic training - A review","volume":"86","author":"Sohrabi","year":"2021","journal-title":"Int J Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-023-00707-x","article-title":"Novel lncRNA Gm33149 modulates metastatic heterogeneity in melanoma by regulating the miR-5623-3p\/Wnt axis via exosomal transfer","volume":"31","author":"Chen","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-061616-030146","article-title":"Stem cell extracellular vesicles: extended messages of regeneration","volume":"57","author":"Riazifar","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.tranon.2024.102152","article-title":"Proteomic and metabolomic profiles of plasma-derived Extracellular Vesicles Differentiate melanoma patients from healthy contorls","volume":"50","author":"Bollard","year":"2024","journal-title":"Trans Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164157","article-title":"The fatty acid and protein profiles of circulating CD81-positive small extracellular vesicles are associated with disease stage in melanoma patients","volume":"13","author":"Paolino","year":"2021","journal-title":"Cancers"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4455","article-title":"Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis","volume":"71","author":"Hood","year":"2011","journal-title":"Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155410","article-title":"Exosomal miR-19a derived from melanoma cell promotes the vemurafenib resistance of Malignant melanoma through directly targeting LRIG1 to reactivate AKT and MAPK pathway","volume":"260","author":"Luan","year":"2024","journal-title":"Pathol Res Pract"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2019.04.011","article-title":"Exosome-mediated metastasis: communication from a distance","volume":"49","author":"Wortzel","year":"2019","journal-title":"Dev Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1479-5876-3-10","article-title":"Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial","volume":"3","author":"Escudier","year":"2005","journal-title":"J Transl Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1731250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:22:38Z","timestamp":1769664158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1731250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":30,"alternative-id":["10.3389\/fonc.2026.1731250"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1731250","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"1731250"}}